IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia has a market size of €6.2bn in 2026 with annual revenue growth of 1.7 %. This division includes the manufacture of basic pharmaceutical products and pharmaceutical preparations. This includes also the manufacture of medicinal chemical and botanical products.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of February 2026.
The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia operates under the industry code RU-C210. This division includes the manufacture of basic pharmaceutical products and pharmaceutical preparations. This includes also the manufacture of medicinal chemical and botanical products. Related terms covered in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia include api (active pharmaceutical ingredient), biosimilars and orphan drug.
Products and services covered in Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia include .
The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia is highly fragmented with no companies holding a market share greater than 5%.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Cafes and Coffee Shops industry in Australia. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia is €6.2bn in 2026.
There are 1,765 businesses in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia, which has grown at a CAGR of 5.0 % between 2019 and 2024.
The market size of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia has been declining at a CAGR of 15.0 % between 2019 and 2024.
Over the next five years, the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia is expected to grow.
Medicinal active substances and Processing of blood are part of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia.
The level of competition is moderate and steady in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Russia.